These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 13868186)

  • 1. [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].
    BERNHEIMER H; BIRKMAYER W; HORNYKIEWICZ O
    Klin Wochenschr; 1961 Oct; 39():1056-9. PubMed ID: 13868186
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin metabolism in paralysis agitans.
    RESNICK RH; GRAY SJ; KOCH JP; TIMBERLAKE WH
    Proc Soc Exp Biol Med; 1962 May; 110():77-9. PubMed ID: 14491558
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome.
    Stahl SM
    CNS Spectr; 2016 Oct; 21(5):355-359. PubMed ID: 27686027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered serotonin metabolism in depressed patients with parkinson's disease.
    Mayeux R; Stern Y; Cote L; Williams JB
    Neurology; 1984 May; 34(5):642-6. PubMed ID: 6200801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of alpha-methyldopa on the metabolism of 5-hydroxytryptamine in rat brain.
    SHARMAN DF; SMITH SE
    J Neurochem; 1962; 9():403-6. PubMed ID: 13911386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cortisone and the 5-hydroxytryptamine content of the brain].
    KATO R; VALZELLI L
    Boll Soc Ital Biol Sper; 1958 Nov; 34(21):1402-4. PubMed ID: 13607802
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of isonicotinic acid hydrazide on 5-hydroxytryptamine metabolism in brain].
    PLETSCHER A
    Experientia; 1956 Dec; 12(12):479-80. PubMed ID: 13397537
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixation of 5-hydroxytryptamine by brain mitochondria.
    WALASZEK E; ABOOD LG
    Proc Soc Exp Biol Med; 1959 May; 101(1):37-40. PubMed ID: 13658183
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Hydroxytryptamine levels in brain of mice pretreated with Alpha-methyl-dopa.
    LEROY JG
    Arch Int Pharmacodyn Ther; 1961 Dec; 134():492-6. PubMed ID: 14464270
    [No Abstract]   [Full Text] [Related]  

  • 10. [The 5-hydroxytryptamine content of various areas of the brain of dogs after electroshock].
    FRESIA P; GENOVESE E; KATO R; VALZELLI L
    Boll Soc Ital Biol Sper; 1958 Nov; 34(21):1397-9. PubMed ID: 13607800
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the influence of alkyl phosphates on the 5-hydroxytryptamine content of the rat brain].
    HEYE D; HILDEBRANDT HJ; SCHWABE U
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961; 241():197-8. PubMed ID: 13714060
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective depletion of noradrenaline and 5-hydroxytryptamine from rat brain and intestine by Rauwolfia alkaloids.
    KARKI NT; PAASONEN MK
    J Neurochem; 1959 Feb; 3(4):352-7. PubMed ID: 13642070
    [No Abstract]   [Full Text] [Related]  

  • 13. Antagonism between harmaline and longacting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brain.
    PLETSCHER A; BESENDORF H
    Experientia; 1959 Jan; 15(1):25-6. PubMed ID: 13619675
    [No Abstract]   [Full Text] [Related]  

  • 14. [5-Hydroxytryptamine level in the rhombencephalon of mice exposed to high temperatures].
    SOCHANSKI R; SAMEK D
    Acta Physiol Pol; 1962; 13():407-11. PubMed ID: 13914725
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical neuropathology of Parkinson's disease.
    Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
    Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correction by nicotinamide and nicotinoyl-GABA of dopamine metabolism in rat brain in experimental Parkinson's disease].
    Kuchmerovs'ka TM; Donchenko HV; Fomenko HI; Chichkovs'ka HV; Pakirbaieva LV; Klymenko AN
    Ukr Biokhim Zh (1999); 2001; 73(6):108-12. PubMed ID: 12199067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of intracarotidly injected serotonin in the brain.
    Costa E; Aprison MH
    Am J Physiol; 1958 Jan; 192(1):95-100. PubMed ID: 13498157
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine action and disorders of neurotransmitter balance.
    Birkmayer W; Birkmayer JD
    Gerontology; 1987; 33(3-4):168-71. PubMed ID: 3653699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.
    Sitte HH; Pifl C; Rajput AH; Hörtnagl H; Tong J; Lloyd GK; Kish SJ; Hornykiewicz O
    Eur J Neurosci; 2017 Jan; 45(1):192-197. PubMed ID: 27741357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.